Literature DB >> 31796466

Chemoprevention of Colorectal Cancer by Anthocyanidins and Mitigation of Metabolic Shifts Induced by Dysbiosis of the Gut Microbiome.

Ashley M Mudd1, Tao Gu2, Radha Munagala3,4, Jeyaprakash Jeyabalan3, Nejat K Egilmez2, Ramesh C Gupta5,3.   

Abstract

Diets rich in fat, smoking, as well as exposure to environmental pollutants and dysbiosis of gut microbiota, increase the risk of developing colorectal cancer. Much progress has been made in combating colorectal cancer. However, options for chemoprevention from environmental insult and dysbiosis of gut microbiota remain elusive. We investigated the influence of berry-derived anthocyanidins (Anthos), with and without encapsulating them in bovine milk-derived exosomes (ExoAnthos), on the chemoprevention of bacteria-driven colon tumor development. Anthos and ExoAnthos treatment of colon cancer cells showed dose-dependent decreases in cell viability. Calculated selectivity index (SI) values for Anthos and ExoAnthos suggest that both treatments selectively targeted cancer over normal colon cells. In addition, ExoAnthos treatment yielded higher SI values than Anthos. Anthos and ExoAnthos treatment of ApcMin/+ mice inoculated with enterotoxigenic Bacteriodes fragilis (ETBF) bacteria led to significant decreases in colon tumor numbers over mice receiving vehicle treatments. Western blot analysis of normal colon, colon tumor, and liver tissue lysates showed that mice inoculated with ETBF featured increased expression of phase I enzymes in normal colon tissue and decreased expression of phase II enzymes in liver tissue. Treatment with the Anthos and ExoAnthos reverted the modulation of phase I and phase II enzymes, respectively; no significant changes in phase II enzyme expression occurred in colon tumor tissue. Treatment of HCT-116 cells with the ubiquitous carcinogen, benzo[a]pyrene (B[a]P) led to similar modulation of phase I and II enzymes, which was partially mitigated by treatment with Anthos. These results provide a promising outlook on the impact of berry Anthos for prevention and treatment of bacteria- and B[a]P-driven colorectal cancer. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31796466      PMCID: PMC6954290          DOI: 10.1158/1940-6207.CAPR-19-0362

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  39 in total

1.  Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats.

Authors:  Geeta Lala; Minnie Malik; Cuiwei Zhao; Jian He; Youngjoo Kwon; M Monica Giusti; Bernadene A Magnuson
Journal:  Nutr Cancer       Date:  2006       Impact factor: 2.900

Review 2.  Anthocyanins: natural colorants with health-promoting properties.

Authors:  Jian He; M Monica Giusti
Journal:  Annu Rev Food Sci Technol       Date:  2010

3.  Exosomal formulation of anthocyanidins against multiple cancer types.

Authors:  Radha Munagala; Farrukh Aqil; Jeyaprakash Jeyabalan; Ashish K Agrawal; Ashley M Mudd; Al Hassan Kyakulaga; Inder P Singh; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Lett       Date:  2017-02-12       Impact factor: 8.679

4.  Milk-derived exosomes for oral delivery of paclitaxel.

Authors:  Ashish K Agrawal; Farrukh Aqil; Jeyaprakash Jeyabalan; Wendy A Spencer; Joshua Beck; Beth W Gachuki; Sara S Alhakeem; Karine Oben; Radha Munagala; Subbarao Bondada; Ramesh C Gupta
Journal:  Nanomedicine       Date:  2017-03-11       Impact factor: 5.307

5.  Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.

Authors:  Ki-Jong Rhee; Shaoguang Wu; Xinqun Wu; David L Huso; Baktiar Karim; Augusto A Franco; Shervin Rabizadeh; Jonathan E Golub; Lauren E Mathews; Jai Shin; R Balfour Sartor; Douglas Golenbock; Abdel R Hamad; Christine M Gan; Franck Housseau; Cynthia L Sears
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

6.  Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).

Authors:  Shujuan Chen; Mei-Fei Yueh; Cyril Bigo; Olivier Barbier; Kepeng Wang; Michael Karin; Nghia Nguyen; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

7.  Pilot study of oral anthocyanins for colorectal cancer chemoprevention.

Authors:  Sarah Thomasset; David P Berry; Hong Cai; Kevin West; Tim H Marczylo; Debbie Marsden; Karen Brown; Ashley Dennison; Giuseppe Garcea; Andrew Miller; David Hemingway; William P Steward; Andreas J Gescher
Journal:  Cancer Prev Res (Phila)       Date:  2009-07

Review 8.  Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer.

Authors:  Maimon C Rose; Elina Kostyanovskaya; R Stephanie Huang
Journal:  Genomics Proteomics Bioinformatics       Date:  2014-10-28       Impact factor: 7.691

9.  A HIF-1α-driven feed-forward loop augments HIF signalling in Hep3B cells by upregulation of ARNT.

Authors:  M Mandl; M-K Lieberum; R Depping
Journal:  Cell Death Dis       Date:  2016-06-30       Impact factor: 8.469

Review 10.  The Different Mechanisms of Cancer Drug Resistance: A Brief Review.

Authors:  Behzad Mansoori; Ali Mohammadi; Sadaf Davudian; Solmaz Shirjang; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2017-09-25
View more
  4 in total

Review 1.  Understanding the Functional Activity of Polyphenols Using Omics-Based Approaches.

Authors:  Wenjin Si; Yangdong Zhang; Xiang Li; Yufeng Du; Qingbiao Xu
Journal:  Nutrients       Date:  2021-11-05       Impact factor: 5.717

Review 2.  The Effects and Mechanisms of Flavonoids on Cancer Prevention and Therapy: Focus on Gut Microbiota.

Authors:  Man Wang; Fei Yu; Yuan Zhang; Wenguang Chang; Meng Zhou
Journal:  Int J Biol Sci       Date:  2022-01-24       Impact factor: 6.580

Review 3.  Anticancer Effects of Lingonberry and Bilberry on Digestive Tract Cancers.

Authors:  Tuulia Onali; Anne Kivimäki; Matti Mauramo; Tuula Salo; Riitta Korpela
Journal:  Antioxidants (Basel)       Date:  2021-05-26

4.  Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway.

Authors:  Farrukh Aqil; Radha Munagala; Ashish K Agrawal; Jeyaprakash Jeyabalan; Neha Tyagi; Shesh N Rai; Ramesh C Gupta
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.